Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pleural Effusion, Malignant: later-stage trial registry
2 of 4 indexed Pleural Effusion, Malignant trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Pleural Effusion, Malignant: 4 US clinical trials tracked, 2 recruiting.
Pleural Effusion, Malignant is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Travera, running 1 of these trials.
Enrollment posture brief
Registry condition pleural-effusion-malignant
OPEN 2 | RECR 50% | LATE 2 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Pleural Effusion, Malignant lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pleural Effusion, Malignant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pleural Effusion, Malignant is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Travera
NCT05461430
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
David Bartlett, MD
NCT07192900
Non-small Cell Lung Cancer Registry
Novartis Pharmaceuticals
NCT00099541
Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter
Duke University
NCT00978939
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Pleural Effusion, Malignant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pleural Effusion, Malignant trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pleural Effusion, Malignant page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Pleural Effusion, Malignant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Travera sponsors the most Pleural Effusion, Malignant trials on record, review their full trial history before evaluating a specific study. See Travera's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pleural Effusion, Malignant condition card totals 4 registered trials; most-linked intervention Aggressive Drainage Instructions; top US site state Colorado. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.